Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions

Neoplasia

Volumn 11, Issue 9, 2009, Pages 856-863

  Palmowski, Moritz ^a   Peschke, Peter ^b   Huppert, Jochen ^c   Hauff, Peter ^d   Reinhardt, Michael ^d   Maurer, Mathias ^e   Karger, Christian P ^c   Scholz, Michael ^f   Semmler, Wolfhard ^c   Huber, Peter E ^b   Kiessling, Fabian M ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d BAYER PHARMA AG   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; CYANOACRYLATE; INTERCELLULAR ADHESION MOLECULE 1; TUMOR MARKER; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CANCER MODEL; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOPPLER FLOWMETRY; EXPERIMENTAL NEOPLASM; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; ION THERAPY; MALE; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BINDING; PROTEIN EXPRESSION; RADIATION DOSE; RAT; TUMOR VASCULARIZATION;

ANIMALS; CARBON RADIOISOTOPES; IMMUNOENZYME TECHNIQUES; INTEGRIN ALPHAVBETA3; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICROBUBBLES; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; RATS; RATS, NUDE; ULTRASONOGRAPHY, DOPPLER; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 69249121184     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09540     Document Type: Article

References (26)

1. Ferrara N and Kerbel RS (2005). Angiogenesis as a therapeutic target. Nature 438, 967-974.
2. Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, and Huber PE (2008). Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res 14, 2210-2219.
3. Huber PE, Bischof M, Jenne J, Heiland S, Peschke P, Saffrich R, Gröne HJ, Debus J, Lipson KE, and Abdollahi A (2005). Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. Cancer Res 65, 3643-3655.
4. 3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clin Cancer Res 11, 6270-6279.
5. Abdollahi A, Lipson KE, Han X, Krempien R, Trinh T, Weber KJ, Hahnfeldt P, Hlatky L, Debus J, Howlett AR, et al. (2003). SU5416 and SU6668 decrease angiogenic effects of radiation-induced factor productions by tumor cells and amplify the direct anti-endothelial action of radiation in vitro. Cancer Res 63, 3755-3763.
6. 3 integrin in melanoma cells: effects on metastatic potential. Radiat Res 130, 281-288.
7. v antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. Proc Natl Acad Sci USA 96, 1591-1596.
8. 3 expression. Cancer Metastasis Rev 27, 631-644.
9. Cai W, Rao J, Gambhir SS, and Chen X (2006). How molecular imaging is speeding up antiangiogenic drug development. Mol Cancer Ther 5, 2624-2633.
10. 3 expression using fluorescence-mediated tomography. Eur J Nucl Med Mol Imaging 34, 745-754.
11. Lindner JR (2004). Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 3, 527-532.
12. Klibanov AL (2006). Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 41, 354-362.
13. Kiessling F, Huppert J, and Palmowski M (2009). Functional and molecular ultrasound imaging: concepts and contrast agents. Curr Med Chem 16, 627-642.
14. Palmowski M, Huppert J, Ladewig G, Hauff P, Reinhardt M, Mueller MM, Woenne EC, Jenne JW, Maurer M, Kauffmann GW, et al. (2008). Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of anti-angiogenic therapy effects. Mol Cancer Ther 7, 101-109.
15. Takahashi Y, Teshima T, Kawaguchi N, Hamada Y, Mori S, Madachi A, Ikeda S, Mizuno H, Ogata T, Nojima K, et al. (2003). Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res 63, 4253-4257.
16. Ogata T, Teshima T, Kagawa K, Hishikawa Y, Takahashi Y, Kawaguchi A, Suzumoto Y, Nojima K, Furusawa Y, and Matsuura N (2005). Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res 65, 113-120.
17. Palmowski M, Morgenstern B, Hauff P, Reinhardt M, Huppert J, Maurer M, Woenne EC, Doerk S, Ladewig G, Jenne JW, et al. (2008). Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging. Invest Radiol 43, 162-169.
18. Dunning WF (1963). Prostate cancer in the rat. Biology of the prostate and related tissues. Natl Cancer Inst Monogr 12, 351-369.
19. Reinhardt M, Hauff P, Briel A, Uhlendorf V, Linker RA, Mäurer M, and Schirner M (2005). Sensitive particle acoustic quantification (SPAQ): a new ultrasound-based approach for the quantification of ultrasound contrast media in high concentrations. Invest Radiol 40, 2-7.
20. 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. Int J Radiat Oncol Biol Phys 65, 1536-1543.
21. Heldin CH, Rubin K, Pietras K, and Ostman A (2004). High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 4, 806-813.
22. Palmowski M, Huppert J, Hauff P, Reinhardt M, Schreiner K, Socher MA, Hallscheidt P, Kauffmann GW, Semmler W, and Kiessling F (2008). Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive 3D high-frequency Doppler ultrasound respond differently to antiangiogenic treatment. Cancer Res 68, 7042-7049.
23. 3. Circulation 108, 336-341.
24. Gaugler MH, Squiban C, van der Meeren A, Bertho JM, Vandame M, and Mouthon MA (1997). Late and persistent up-regulation of intercellular adhesion molecule-1 (ICAM-1) expression by ionizing radiation in human endothelial cells in vitro. Int J Radiat Biol 72, 201-209.
25. 3 integrin in human melanoma cells. Eur J Cancer 36, 410-422.
26. Burke PA, DeNardo SJ, Miers LA, Lamborn KR, Matzku S, and DeNardo GL (2002). Cilengitide targeting of α(v)β(3) integrin receptor synergizes with radio-immunotherapy to increase efficacy and apoptosis in breast cancer xenografts. Cancer Res 62, 4263-4272.